Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-08-09

Clinical Trial Update: A New Active Vitamin D, ED-71 for Osteoporosis [Phase 3]

View source ↗

Summary

Phase 3 trial of ED-71, an active vitamin D compound, for osteoporosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ED-71

Snippet

Sponsor: Chugai Pharmaceutical | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED